Brian Elsbernd - 20 Mar 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Compliance/Legal Officer
Signature
/s/ Brian Elsbernd
Issuer symbol
CPRX
Transactions as of
20 Mar 2023
Net transactions value
-$746,950
Form type
4
Filing time
22 Mar 2023, 16:45:42 UTC
Previous filing
17 Feb 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Options Exercise $56,500 +50,000 +36% $1.13* 188,076 20 Mar 2023 Direct
transaction CPRX Common Stock, par value $0.001 per share Sale $803,450 -50,000 -27% $16.07 138,076 20 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to Purchase Common Stock Options Exercise $0 -50,000 -5.5% $0.000000 860,334 20 Mar 2023 Common Stock 50,000 $1.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Elsbernd sold the shares in the open market for personal reasons and not as a result of a disagreement with the Company. Mr. Elsbernd remains an executive officer of the Company.
F2 Represents the weighted average price for the shares sold. Shares were sold in various lots ranging from $16.01 to $16.23 per share.
F3 Options vested in three annual tranches beginning on 1/3/2018.